● Recruiting

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Condition: Pleural Effusion · Heart Failure · Malignant Neoplasm · Sponsor: Chinese University of Hong Kong

PhaseN/A

Planned participants120

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To assess the discriminative properties of pleural fluid (PF) N-terminal-proB-type-natriuretic-peptide (NTproBNP) levels in identifying heart failure (HF)-associated pleural effusions (PE).

This description comes directly from the study's public registry record.

Talk to the study team

Christopher Chan, MBChB · 35053396 · christopherchan@cuhk.edu.hk

Ken KP Chan, MBChB · 35053396 · chankapang@cuhk.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Prince of Wales Hospital

Hong Kong, New Territories, Hong Kong

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05797649